Do Foundation Models Actually Improve Microbiome Disease Prediction?

The Reality of Microbiome Disease Prediction

Artificial intelligence foundation models currently offer only modest gains over classical machine learning techniques when analysing human gut bacteria. Achieving reliable microbiome disease prediction has historically been exceptionally difficult because bacterial data is sparse, highly variable, and prone to extreme differences between distinct patient groups.

Scientists have long struggled with inter-study heterogeneity. An algorithm trained to detect gut dysbiosis in one clinical study often fails entirely when applied to patients in a different cohort. Theoretically, large language models and foundation models could bypass this by identifying deeper, universal patterns across massive datasets.

Benchmarking the Algorithms

In a comprehensive, early-stage, non-peer-reviewed preprint, researchers systematically tested these modern AI approaches against traditional techniques. They evaluated 83 publicly curated case-control cohorts spanning 20 different diseases, using both 16S rRNA sequencing and shotgun metagenomics data.

The team compared new tools—including GPT-derived semantic embeddings, a general tabular foundation model (TabPFN), and a microbiome-specific foundation model (MGM)—against classical baselines. These baselines included regularised logistic regression and standard random forests.

Within the scope of these specific dataset parameters, the measured outcomes were highly revealing. GPT-derived embeddings consistently underperformed standard numerical methods across the board. While the general-purpose TabPFN achieved strong out-of-the-box results, it did not reliably beat well-tuned classical methods when tested across different patient cohorts.

What This Preliminary Study Does Not Solve

This research clearly demonstrates that applying larger, more complex AI to bacterial data does not automatically fix underlying biological variability. The preprint does not solve the fundamental problem of cross-cohort transferability.

Specifically, the microbiome-specific foundation model (MGM) actually lagged behind older tabular methods. This suggests that current models, which are pre-trained at the broad 'genus' level of bacterial classification, lack the specific resolution needed to overcome study-to-study differences. Furthermore, the researchers found that standard batch-effect correction methods provided only limited and inconsistent improvements.

Future Directions for Clinical AI

These early-stage findings indicate that standard numerical representations remain the benchmark. For computational biologists and clinical diagnosticians, older, simpler models are still highly competitive and often more robust.

Moving forward, developers may need to fundamentally rethink how they train microbiome-specific algorithms. To translate pretraining into reliable generalisation across different studies, future models will likely require:

• Massively increased pretraining data scales to capture global variations.
• Finer taxonomic resolution, moving past genus-level classifications to specific bacterial strains.
• Entirely new architectural designs tailored specifically to compositional biological data.

Until these technical hurdles are cleared, researchers should remain rigorous and sceptical. The newest algorithm is not always the most effective tool in the laboratory.